TopiVert Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:TopiVert Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013473
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TopiVert Ltd (TopiVert) is a drug development company that offers disease control solutions in inflammatory diseases of the gastrointestinal tract and the eye. The company develops and offers narrow spectrum kinase inhibitors (NSKI) for the treatment of chronic inflammatory diseases of gastrointestinal and eye. It develops various drug candidates which include TOP1288 which is intended for the treatment of ulcerative colitis, a chronic, relapsing inflammatory condition. The company also offers TOP1630, a candidate used in treatment of dry eye diseases. TopiVert is headquartered in London, the UK.

TopiVert Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TopiVert Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
TopiVert Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
TopiVert Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
TopiVert Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
TopiVert Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
TopiVert Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
TopiVert Raises USD28 Million in Venture Financing 10
TopiVert Raises US$7.4 Million In Venture Financing 12
Topivert Raises US$12.5 Million In Venture Financing 14
Partnerships 15
Topivert Enters into Drug Discovery Collaboration Agreement with RespiVert 15
Licensing Agreements 16
Topivert Enters into Licensing Agreement with RespiVert 16
TopiVert Ltd – Key Competitors 17
TopiVert Ltd – Key Employees 18
TopiVert Ltd – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Clinical Trials 20
May 16, 2016: TopiVert completes preclinical development with TOP1630 for dry eye disease 20
May 09, 2016: TopiVert to Present First in Human Data From Its Phase I Clinical Study With TOP1288 at DDW 2016 in San Diego 21
Mar 17, 2016: TopiVert Reports Successful Phase I Study With TOP1288 for the Treatment Of Ulcerative Colitis 22
Mar 07, 2016: TopiVert to Present First-In-Human Data From Its Phase I Clinical Study With TOP1288 for the Treatment of Ulcerative Colitis at the Forthcoming 11th Congress of ECCO in Amsterdam 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
TopiVert Ltd, Pharmaceuticals & Healthcare, Key Facts 2
TopiVert Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
TopiVert Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
TopiVert Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
TopiVert Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
TopiVert Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
TopiVert Raises USD28 Million in Venture Financing 10
TopiVert Raises US$7.4 Million In Venture Financing 12
Topivert Raises US$12.5 Million In Venture Financing 14
Topivert Enters into Drug Discovery Collaboration Agreement with RespiVert 15
Topivert Enters into Licensing Agreement with RespiVert 16
TopiVert Ltd, Key Competitors 17
TopiVert Ltd, Key Employees 18

★海外企業調査レポート[TopiVert Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Qatar National Bank (QNBK):企業の財務・戦略的SWOT分析
    Qatar National Bank (QNBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Energy Transfer Partners, L.P.:企業の戦略・SWOT・財務情報
    Energy Transfer Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Energy Transfer Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Ontario Power Generation Inc:電力:M&Aディール及び事業提携情報
    Summary Ontario Power Generation Inc (OPG) is an electric utility. It generates and sells energy. The company produces power from nuclear, hydro, and thermal sources. OPG has long-term lease arrangement and related agreements with Bruce Power related to the Bruce nuclear generating stations. It also …
  • Evoqua Water Technologies Corp (AQUA):企業の財務・戦略的SWOT分析
    Evoqua Water Technologies Corp (AQUA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Synchrony Financial
    Synchrony Financial - Strategy, SWOT and Corporate Finance Report Summary Synchrony Financial - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Bayer AG (BAYN)-医療機器分野:企業M&A・提携分析
    Summary Bayer AG (Bayer) carries out the research, development, production and commercialization of products in the areas of human and animal health care, and agriculture. It provides pharmaceuticals for cardiology, women’s healthcare, oncology, hematology, ophthalmology, infection and other indicat …
  • JHL Biotech Inc:医療機器:M&Aディール及び事業提携情報
    Summary JHL Biotech Inc (JHL Biotech) is a biologic medicines provider. The company offers cell line construction, process development, manufacturing, quality and regulatory services. It offers products such as biosimilar rituximab, biosimilar dornase alfa, biosimilar bevacizumab, biosimilar trastuz …
  • Noxilizer Inc-医療機器分野:企業M&A・提携分析
    Summary Noxilizer Inc (Noxilizer) is a medical device company that manufactures sterilization equipment. The company’s products include industrial nitrogen dioxide sterilizer and biodecontamination systems. Its services comprise installation, contract sterilization services, and maintenance services …
  • Intuitive Surgical Inc (ISRG):企業の財務・戦略的SWOT分析
    Intuitive Surgical Inc (ISRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Qatar Electricity & Water Company QSC:発電所・企業SWOT分析
    Qatar Electricity & Water Company QSC - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Bureau Veritas SA (BVI):電力:M&Aディール及び事業提携情報
    Summary Bureau Veritas SA (Bureau Veritas) is a provider of testing, inspection and certification services. The company offers asset management, certification, consulting, inspection and audits, testing and analysis, and training. It serves aeronautics, agriculture, automotive, construction and real …
  • Vital Therapies Inc (VTL)-医療機器分野:企業M&A・提携分析
    Summary Vital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute l …
  • Electric Power Development Co Ltd (9513):企業の財務・戦略的SWOT分析
    Electric Power Development Co Ltd (9513) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Fidelity Life Assurance of Zimbabwe Ltd:企業の戦略・SWOT・財務情報
    Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report Summary Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Chubu Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    Chubu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Chubu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • The Saudi British Bank (1060):企業の財務・戦略的SWOT分析
    The Saudi British Bank (1060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Deutz AG (DEZ):企業の財務・戦略的SWOT分析
    Deutz AG (DEZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Cesca Therapeutics Inc (KOOL)-医療機器分野:企業M&A・提携分析
    Summary Cesca Therapeutics Inc (Cesca) researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cell-based therapies for the in the vascular and orthopedic markets. Its device di …
  • Ocado Group Plc:企業の戦略・SWOT・財務情報
    Ocado Group Plc - Strategy, SWOT and Corporate Finance Report Summary Ocado Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Sellier & Bellot J.S.C.:企業の戦略・SWOT・財務分析
    Sellier & Bellot J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Sellier & Bellot J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆